HEADER SERINE PROTEASE INHIBITOR 01-APR-97 2REL TITLE SOLUTION STRUCTURE OF R-ELAFIN, A SPECIFIC INHIBITOR OF ELASTASE, NMR, TITLE 2 11 STRUCTURES COMPND MOL_ID: 1; COMPND 2 MOLECULE: R-ELAFIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 OTHER_DETAILS: THE POLYPEPTIDE MAY BE OBTAINED BY EXPRESSION USING SOURCE 8 PLASMIDIC EXPRESSION SYSTEMS IN HOSTS SUCH AS ESCHERICHIA COLI AND SOURCE 9 YEAST, THE POLYPEPTIDE BEING ALSO OBTAINABLE FROM PSORIATIC PLAQUES. SOURCE 10 PATENT NUMBER 5,464,822 DATE OF PATENT NOV. 7, 1995 BY CHRISTOPHERS SOURCE 11 E., WIEDOW O., SCHRODER J.M. THE PROTEIN WAS PROVIDED BY ZENECA SOURCE 12 PHARMACEUTICALS. KEYWDS SERINE PROTEASE INHIBITOR, R-ELAFIN, ELASTASE INHIBITOR EXPDTA SOLUTION NMR NUMMDL 11 AUTHOR C.FRANCART,M.DAUCHEZ,A.J.P.ALIX,G.LIPPENS REVDAT 3 29-NOV-17 2REL 1 REMARK HELIX REVDAT 2 24-FEB-09 2REL 1 VERSN REVDAT 1 07-JUL-97 2REL 0 SPRSDE 07-JUL-97 2REL 1REL JRNL AUTH C.FRANCART,M.DAUCHEZ,A.J.ALIX,G.LIPPENS JRNL TITL SOLUTION STRUCTURE OF R-ELAFIN, A SPECIFIC INHIBITOR OF JRNL TITL 2 ELASTASE. JRNL REF J.MOL.BIOL. V. 268 666 1997 JRNL REFN ISSN 0022-2836 JRNL PMID 9171290 JRNL DOI 10.1006/JMBI.1997.0983 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.TSUNEMI,H.KATO,Y.NISHIUCHI,S.KUMAGAYE,S.SAKAKIBARA REMARK 1 TITL SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIPS OF ELAFIN, AN REMARK 1 TITL 2 ELASTASE-SPECIFIC INHIBITOR REMARK 1 REF BIOCHEM.BIOPHYS.RES.COMMUN. V. 185 967 1992 REMARK 1 REFN ISSN 0006-291X REMARK 1 REFERENCE 2 REMARK 1 AUTH O.WIEDOW,J.M.SCHRODER,H.GREGORY,J.A.YOUNG,E.CHRISTOPHERS REMARK 1 TITL ERRATUM. ELAFIN: AN ELASTASE-SPECIFIC INHIBITOR OF HUMAN REMARK 1 TITL 2 SKIN. PURIFICATION, CHARACTERIZATION, AND COMPLETE AMINO REMARK 1 TITL 3 ACID SEQUENCE REMARK 1 REF J.BIOL.CHEM. V. 266 3356 1991 REMARK 1 REFN ISSN 0021-9258 REMARK 1 REFERENCE 3 REMARK 1 AUTH O.WIEDOW,J.M.SCHRODER,H.GREGORY,J.A.YOUNG,E.CHRISTOPHERS REMARK 1 TITL ELAFIN: AN ELASTASE-SPECIFIC INHIBITOR OF HUMAN SKIN. REMARK 1 TITL 2 PURIFICATION, CHARACTERIZATION, AND COMPLETE AMINO ACID REMARK 1 TITL 3 SEQUENCE REMARK 1 REF J.BIOL.CHEM. V. 265 14791 1990 REMARK 1 REFN ISSN 0021-9258 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2REL COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000178555. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 293 REMARK 210 PH : 7.0 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : NULL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : TOCSY; NOESY; DQFCOSY; 1H-13C REMARK 210 HSQC; 1H-13C HSQC-TOCSY; 1H-13C REMARK 210 HSQC-NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : DMX 600 REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : X-PLOR 3.1 REMARK 210 METHOD USED : DISTANCE GEOMETRY, SIMULATED REMARK 210 ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 11 REMARK 210 CONFORMERS, SELECTION CRITERIA : NOE AND DIHEDRAL ANGLE REMARK 210 VIOLATIONS, ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 VAL A 5 -88.80 51.88 REMARK 500 1 PRO A 8 -153.19 -77.93 REMARK 500 1 VAL A 9 42.07 -83.46 REMARK 500 1 SER A 10 108.60 59.99 REMARK 500 1 PRO A 13 -93.16 -77.46 REMARK 500 1 ILE A 18 123.81 62.62 REMARK 500 1 LEU A 20 -87.42 37.11 REMARK 500 1 ILE A 21 -85.27 -150.15 REMARK 500 1 ARG A 22 35.18 -173.87 REMARK 500 1 CYS A 23 91.36 5.13 REMARK 500 1 ALA A 24 61.49 -101.86 REMARK 500 1 MET A 25 -100.12 -96.07 REMARK 500 1 LEU A 26 -134.23 -117.68 REMARK 500 1 LEU A 33 -60.54 -158.04 REMARK 500 1 ILE A 41 58.13 -117.95 REMARK 500 1 CYS A 45 -159.64 -124.78 REMARK 500 1 SER A 48 85.46 44.52 REMARK 500 1 CYS A 49 104.25 87.40 REMARK 500 1 ALA A 52 -170.40 -170.90 REMARK 500 2 GLN A 2 71.34 -163.25 REMARK 500 2 VAL A 5 168.42 -43.89 REMARK 500 2 LYS A 6 -148.13 -106.51 REMARK 500 2 SER A 15 73.58 -109.14 REMARK 500 2 PRO A 17 -157.49 -81.84 REMARK 500 2 ILE A 21 92.79 117.95 REMARK 500 2 ARG A 22 39.30 27.32 REMARK 500 2 CYS A 23 21.68 38.06 REMARK 500 2 ALA A 24 -87.41 45.78 REMARK 500 2 MET A 25 102.78 -5.22 REMARK 500 2 ASN A 27 80.47 58.74 REMARK 500 2 LEU A 33 -41.35 -152.39 REMARK 500 2 LYS A 34 -32.67 174.44 REMARK 500 2 ASP A 35 -77.14 -41.32 REMARK 500 2 THR A 36 -36.15 172.45 REMARK 500 2 ASP A 37 94.51 -42.33 REMARK 500 2 CYS A 38 65.77 -170.63 REMARK 500 2 ILE A 41 -118.90 -84.24 REMARK 500 2 LYS A 42 -34.58 -142.37 REMARK 500 2 CYS A 49 91.71 78.92 REMARK 500 3 GLN A 2 -68.28 -91.04 REMARK 500 3 GLU A 3 99.73 61.11 REMARK 500 3 PRO A 4 -159.29 -78.66 REMARK 500 3 VAL A 5 -82.80 -68.43 REMARK 500 3 LYS A 6 179.30 170.19 REMARK 500 3 VAL A 9 -94.98 65.67 REMARK 500 3 SER A 10 75.68 -168.62 REMARK 500 3 CYS A 16 166.25 -47.80 REMARK 500 3 ILE A 18 131.14 61.03 REMARK 500 3 ILE A 19 -138.00 -132.76 REMARK 500 3 LEU A 20 -41.30 -161.70 REMARK 500 REMARK 500 THIS ENTRY HAS 228 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 1 ARG A 22 0.26 SIDE CHAIN REMARK 500 1 ARG A 31 0.19 SIDE CHAIN REMARK 500 2 ARG A 22 0.25 SIDE CHAIN REMARK 500 2 ARG A 31 0.31 SIDE CHAIN REMARK 500 3 ARG A 22 0.19 SIDE CHAIN REMARK 500 3 ARG A 31 0.31 SIDE CHAIN REMARK 500 4 ARG A 22 0.11 SIDE CHAIN REMARK 500 4 ARG A 31 0.28 SIDE CHAIN REMARK 500 5 ARG A 22 0.31 SIDE CHAIN REMARK 500 5 ARG A 31 0.12 SIDE CHAIN REMARK 500 6 ARG A 31 0.32 SIDE CHAIN REMARK 500 7 ARG A 22 0.27 SIDE CHAIN REMARK 500 7 ARG A 31 0.32 SIDE CHAIN REMARK 500 8 ARG A 22 0.32 SIDE CHAIN REMARK 500 8 ARG A 31 0.24 SIDE CHAIN REMARK 500 9 ARG A 22 0.30 SIDE CHAIN REMARK 500 9 ARG A 31 0.20 SIDE CHAIN REMARK 500 10 ARG A 22 0.23 SIDE CHAIN REMARK 500 11 ARG A 22 0.29 SIDE CHAIN REMARK 500 11 ARG A 31 0.17 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL DBREF 2REL A 1 57 UNP P19957 ELAF_HUMAN 61 117 SEQRES 1 A 57 ALA GLN GLU PRO VAL LYS GLY PRO VAL SER THR LYS PRO SEQRES 2 A 57 GLY SER CYS PRO ILE ILE LEU ILE ARG CYS ALA MET LEU SEQRES 3 A 57 ASN PRO PRO ASN ARG CYS LEU LYS ASP THR ASP CYS PRO SEQRES 4 A 57 GLY ILE LYS LYS CYS CYS GLU GLY SER CYS GLY MET ALA SEQRES 5 A 57 CYS PHE VAL PRO GLN SHEET 1 A 2 LYS A 42 GLU A 46 0 SHEET 2 A 2 MET A 51 VAL A 55 -1 N PHE A 54 O LYS A 43 SSBOND 1 CYS A 16 CYS A 45 1555 1555 2.02 SSBOND 2 CYS A 23 CYS A 49 1555 1555 2.01 SSBOND 3 CYS A 32 CYS A 44 1555 1555 2.02 SSBOND 4 CYS A 38 CYS A 53 1555 1555 2.02 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1